Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections
- DOI
- 10.1186/s12929-024-01065-y
- Published
- 2024-07-24
- Container
- Journal of Biomedical Science
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12929-024-01065-y,
title = {Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections},
author = {Daria V. Vasina and Nataliia P. Antonova and Vladimir A. Gushchin and Andrey V. Aleshkin and Mikhail V. Fursov and Anastasiia D. Fursova and Petya G. Gancheva and Igor V. Grigoriev and Pavel Grinkevich and Alexey V. Kondratev and Alexey V. Kostarnoy and Anastasiya M. Lendel and Valentine V. Makarov and Maria A. Nikiforova and Andrei A. Pochtovyi and Tatiana Prudnikova and Timofey A. Remizov and Natalia V. Shevlyagina and Andrei E. Siniavin and Nina S. Smirnova and Alexander A. Terechov and Artem P. Tkachuk and Evgeny V. Usachev and Aleksei M. Vorobev and Victoria S. Yakimakha and Sergey M. Yudin and Anastasia A. Zackharova and Vladimir G. Zhukhovitsky and Denis Y. Logunov and Alexander L. Gintsburg},
year = {2024},
journal = {Journal of Biomedical Science},
doi = {10.1186/s12929-024-01065-y},
url = {https://doi.org/10.1186/s12929-024-01065-y}
}RIS
TY - JOUR TI - Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections AU - Daria V. Vasina AU - Nataliia P. Antonova AU - Vladimir A. Gushchin AU - Andrey V. Aleshkin AU - Mikhail V. Fursov AU - Anastasiia D. Fursova AU - Petya G. Gancheva AU - Igor V. Grigoriev AU - Pavel Grinkevich AU - Alexey V. Kondratev AU - Alexey V. Kostarnoy AU - Anastasiya M. Lendel AU - Valentine V. Makarov AU - Maria A. Nikiforova AU - Andrei A. Pochtovyi AU - Tatiana Prudnikova AU - Timofey A. Remizov AU - Natalia V. Shevlyagina AU - Andrei E. Siniavin AU - Nina S. Smirnova AU - Alexander A. Terechov AU - Artem P. Tkachuk AU - Evgeny V. Usachev AU - Aleksei M. Vorobev AU - Victoria S. Yakimakha AU - Sergey M. Yudin AU - Anastasia A. Zackharova AU - Vladimir G. Zhukhovitsky AU - Denis Y. Logunov AU - Alexander L. Gintsburg PY - 2024 JO - Journal of Biomedical Science DO - 10.1186/s12929-024-01065-y UR - https://doi.org/10.1186/s12929-024-01065-y ER -
APA
Vasina, D. V., Antonova, N. P., Gushchin, V. A., Aleshkin, A. V., Fursov, M. V., Fursova, A. D., Gancheva, P. G., Grigoriev, I. V., Grinkevich, P., Kondratev, A. V., Kostarnoy, A. V., Lendel, A. M., Makarov, V. V., Nikiforova, M. A., Pochtovyi, A. A., Prudnikova, T., Remizov, T. A., Shevlyagina, N. V., Siniavin, A. E., Smirnova, N. S., Terechov, A. A., Tkachuk, A. P., Usachev, E. V., Vorobev, A. M., Yakimakha, V. S., Yudin, S. M., Zackharova, A. A., Zhukhovitsky, V. G., Logunov, D. Y., & Gintsburg, A. L. (2024). Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections. Journal of Biomedical Science. https://doi.org/10.1186/s12929-024-01065-y
Source records
- crossref · retrieved 2026-11-07T22:33:03.620Z